Fairfield, Bush & Co. Biocryst Pharmaceuticals Inc Transaction History

Fairfield, Bush & Co.

  • $168 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$4.98 - $6.77 $7,793 - $10,595
1,565 New
1,565 $9.37 Million
Q2 2023

Aug 15, 2023
BUY
$6.96 - $8.81 $10,892 - $13,787
1,565 New
1,565 $11 Million
Q1 2022

May 06, 2022
BUY
$11.56 - $19.76 $23,871 - $40,804
2,065 New
2,065 $34,000

Others Institutions Holding BCRX

# of Institutions
279
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Fairfield, Bush & Co. Portfolio

Follow Fairfield, Bush & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email